Search Result "Schizophrenia/Bipolar Disorder"
Specificity and Continuity of Schizophrenia and Bipolar Disorder: Relation to Biomarkers
Journal: Current Pharmaceutical Design
Volume: 26 Issue: 2 Year: 2020 Page: 191-200
Author(s): Yuji Yamada,Madoka Matsumoto,Kazuki Iijima,Tomiki Sumiyoshi
Schizophrenia and Bipolar Affective Disorder: Perspectives for the Development of Therapeutics
Journal: Current Molecular Medicine
Volume: 3 Issue: 5 Year: 2003 Page: 393-407
Author(s): S. Sundram, P. R. Joyce, M. A. Kennedy
Older and Newer Strategies for the Pharmacological Management of Agitation in Patients with Bipolar Disorder or Schizophrenia
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 8 Year: 2017 Page: 885-890
Author(s): Giovanni Amodeo,Andrea Fagiolini,Gabriele Sachs,Andreas Erfurth
Repurposed Drugs for the Treatment of Schizophrenia and Bipolar Disorders
Journal: Current Topics in Medicinal Chemistry
Volume: 13 Issue: 18 Year: 2013 Page: 2364-2385
Author(s): J. M. Bumb,F. Enning,F. M. Leweke
Brain Structural Abnormalities at the Onset of Schizophrenia and Bipolar Disorder: A Meta-analysis of Controlled Magnetic Resonance Imaging Studies
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 4 Year: 2012 Page: 486-494
Author(s): Luca De Peri, Alessandra Crescini, Giacomo Deste, Paolo Fusar-Poli, Emilio Sacchetti, Antonio Vita
Cellular Pathology in the Dorsolateral Prefrontal Cortex Distinguishes Schizophrenia from Bipolar Disorder
Journal: Current Molecular Medicine
Volume: 3 Issue: 5 Year: 2003 Page: 427-436
Author(s): L. D. Selemon, G. Rajkowska
A Role for Glutathione in the Pathophysiology of Bipolar Disorder and Schizophrenia? Animal Models and Relevance to Clinical Practice
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 2 Year: 2009 Page: 2965-2976
Author(s): O. M. Dean, M. van den Buuse, A.I. Bush, D.L. Copolov, F. Ng, S. Dodd, M. Berk
The Importance of Nicotinic Acetylcholine Receptors in Schizophrenia, Bipolar Disorder and Tourettes Syndrome
Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1 Issue: 4 Year: 2002 Page: 433-442
Author(s): Joseph P. McEvoy, Trina B. Allen
Risk Analysis of Lurasidone in Patients with Schizophrenia and Bipolar Depression
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 19 Issue: 2 Year: 2020 Page: 109-114
Author(s): Harika Modugula,Anoop Kumar
Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study (Supplementry Table)
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 7 Issue: 3 Year: 2009 Page: 164-188
Author(s): S. J. Glatt, S. D. Chandler, C. A. Bousman, G. Chana, G. R. Lucero, E. Tatro, T. May, J. B. Lohr, W. S. Kremen, I. P. Everall, M. T. Tsuang